Society has increasingly high expectations for ethical behavior from global healthcare companies – expectations that very often go beyond what is legally required. We are taking steps to ensure our standards align with these expectations.
“At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine. To achieve this purpose requires an engaged, diverse workforce and an inclusive culture that empowers decision making, inspires innovation, and encourages diversity of thought. It also requires a supplier base that reflects the diversity of the patients we serve and the customers with whom we work. As part of our procurement process, we select preferred partners including small, minority and women-owned companies and other diverse businesses within our supplier community. Just as with our associates, we expect our providers to bring creativity and innovation reflecting diverse experiences and backgrounds. Diversity helps us to achieve our mission to bring high-quality affordable medicines to patients in the US and around the world.”
To the best of our knowledge, as of January 1, 2020, Sandoz is in material compliance with its Comprehensive Compliance Program and the requirements of the California Health & Safety Code. It is Sandoz’s expectation that all employees and contractors comply with its Comprehensive Compliance Program and all policies that support the program. Sandoz is committed to assessing ongoing compliance with its Comprehensive Compliance Program, which is designed to prevent, detect and address potential or actual instances of non-compliance.
We are committed to transparent reporting – a central part of our UN Global Compact obligations. Our Annual Report serves as our primary reporting mechanism for corporate responsibility, and we have published a combined financial and CR report since 2000.
The CR Performance Report is based on the Global Reporting Initiative G4 guidelines, with disclosure at “comprehensive” level, making it the first comprehensive level-report in the healthcare industry.
The Physician Payments Sunshine Act was enacted by Congress in 2010 as part of the healthcare reform law. The Sunshine Act is intended to make relationships between certain pharmaceutical and device manufacturers and healthcare providers more transparent, by requiring applicable manufacturers to report payments and other "transfers of value" provided to physicians and teaching hospitals to the Centers for Medicare and Medicaid Services (CMS). Learn more >